These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 24293274

  • 21. Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.
    Chen M, Lin M, Wang X.
    Oncol Rep; 2018 Feb; 39(2):619-626. PubMed ID: 29207158
    [Abstract] [Full Text] [Related]

  • 22. SIRT2, a direct target of miR-212-5p, suppresses the proliferation and metastasis of colorectal cancer cells.
    Du F, Li Z, Zhang G, Shaoyan S, Geng D, Tao Z, Qiu K, Liu S, Zhou Y, Zhang Y, Gu J, Wang G, Li L, Wu W.
    J Cell Mol Med; 2020 Sep; 24(17):9985-9998. PubMed ID: 32697380
    [Abstract] [Full Text] [Related]

  • 23. MiR-21/RASA1 axis affects malignancy of colon cancer cells via RAS pathways.
    Gong B, Liu WW, Nie WJ, Li DF, Xie ZJ, Liu C, Liu YH, Mei P, Li ZJ.
    World J Gastroenterol; 2015 Feb 07; 21(5):1488-97. PubMed ID: 25663768
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2.
    Li Q, Liang X, Wang Y, Meng X, Xu Y, Cai S, Wang Z, Liu J, Cai G.
    Sci Rep; 2016 May 31; 6():27157. PubMed ID: 27244080
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
    Wu Y, Song Y, Xiong Y, Wang X, Xu K, Han B, Bai Y, Li L, Zhang Y, Zhou L.
    Cell Physiol Biochem; 2017 May 31; 43(3):945-958. PubMed ID: 28957811
    [Abstract] [Full Text] [Related]

  • 29. Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma.
    Luo H, Zou J, Dong Z, Zeng Q, Wu D, Liu L.
    Biochem J; 2012 Mar 01; 442(2):311-21. PubMed ID: 22132820
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer.
    Smits KM, Paranjape T, Nallur S, Wouters KA, Weijenberg MP, Schouten LJ, van den Brandt PA, Bosman FT, Weidhaas JB, van Engeland M.
    Clin Cancer Res; 2011 Dec 15; 17(24):7723-31. PubMed ID: 21994416
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. MicroRNA-520b Functions as a Tumor Suppressor in Colorectal Cancer by Inhibiting Defective in Cullin Neddylation 1 Domain Containing 1 (DCUN1D1).
    Xiao J, Li G, Zhou J, Wang S, Liu D, Shu G, Zhou J, Ren F.
    Oncol Res; 2018 May 07; 26(4):593-604. PubMed ID: 28470146
    [Abstract] [Full Text] [Related]

  • 35. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
    Roshani Asl E, Rasmi Y, Baradaran B.
    J Cell Physiol; 2021 Oct 07; 236(10):7071-7087. PubMed ID: 33821473
    [Abstract] [Full Text] [Related]

  • 36. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
    Kong Y, Bai PS, Sun H, Nan KJ, Chen NZ, Qi XG.
    Int J Biochem Cell Biol; 2012 Dec 07; 44(12):2321-32. PubMed ID: 22903020
    [Abstract] [Full Text] [Related]

  • 37. MicroRNA‑337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
    Liu X, Wang Y, Zhao J.
    Oncol Rep; 2017 Nov 07; 38(5):3187-3196. PubMed ID: 29048669
    [Abstract] [Full Text] [Related]

  • 38. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B, Liu Y, Zhao L, Pan Y, Shan Y, Li Y, Jia L.
    Mol Carcinog; 2017 Dec 07; 56(12):2669-2680. PubMed ID: 28767179
    [Abstract] [Full Text] [Related]

  • 39. PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d.
    Huang L, Wen C, Yang X, Lou Q, Wang X, Che J, Chen J, Yang Z, Wu X, Huang M, Lan P, Wang L, Iwamoto A, Wang J, Liu H.
    Cell Death Dis; 2018 Feb 15; 9(3):271. PubMed ID: 29449544
    [Abstract] [Full Text] [Related]

  • 40. Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer.
    Jung Y, Jun Y, Lee HY, Kim S, Jung Y, Keum J, Lee YS, Cho YB, Lee S, Kim J.
    Oncotarget; 2015 Sep 22; 6(28):25368-80. PubMed ID: 26196590
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.